P G De Groot - JoVE Visualize

Showing results (131-140 of 233) with videos related to

Pageof 24

Sort By:

Biochemical and Biophysical Research Communications|December 17, 1997

Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activationI W Bobbink, W L Tekelenburg, J J Sixma, et al.

The Journal of Laboratory and Clinical Medicine|July 1, 1994

The effect of recombinant human erythropoietin on hemostasis, fibrinolysis, and blood rheology in autologous blood donorsD H Biesma, P J Bronkhorst, P G de Groot, et al.

Arteriosclerosis (Dallas, Tex.)|November 1, 1987

Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward plateletsP G de Groot, C L Verweij, P P Nawroth, et al.

European Journal of Clinical Investigation|October 1, 1983

Endothelial cell dysfunction in homocystinuriaP G de Groot, C Willems, G H Boers, et al.

Journal of Thrombosis and Haemostasis : JTH|August 17, 2005

Lupus anticoagulants and the risk of a first episode of deep venous thrombosisP G de Groot, B Lutters, R H W M Derksen, et al.

Journal of Thrombosis and Haemostasis : JTH|August 7, 2009

Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibalpha and alpha IIb beta 3C J C de Haas, C Weeterings, M M Vughs, et al.

Journal of Thrombosis and Haemostasis : JTH|October 18, 2013

Increased mortality in systemic inflammatory response syndrome patients with high levels of coagulation factor VIIaA Hyseni, H Kemperman, D W de Lange, et al.

Blood|August 1, 1995

Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factorH Lankhof, Y P Wu, T Vink, et al.

Stroke|February 1, 1993

Increased thromboxane biosynthesis in patients with acute cerebral ischemiaP J Koudstaal, G Ciabattoni, J van Gijn, et al.

Journal of Thrombosis and Haemostasis : JTH|November 25, 2003

Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinuxT Lisman, N R Bijsterveld, J Adelmeijer, et al.

Pageof 24

Showing results (131-140 of 233) with videos related to

Sort By:

Pageof 24

Biochemical and Biophysical Research Communications|December 17, 1997

Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activationI W Bobbink, W L Tekelenburg, J J Sixma, et al.

The Journal of Laboratory and Clinical Medicine|July 1, 1994

The effect of recombinant human erythropoietin on hemostasis, fibrinolysis, and blood rheology in autologous blood donorsD H Biesma, P J Bronkhorst, P G de Groot, et al.

Arteriosclerosis (Dallas, Tex.)|November 1, 1987

Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward plateletsP G de Groot, C L Verweij, P P Nawroth, et al.

European Journal of Clinical Investigation|October 1, 1983

Endothelial cell dysfunction in homocystinuriaP G de Groot, C Willems, G H Boers, et al.

Journal of Thrombosis and Haemostasis : JTH|August 17, 2005

Lupus anticoagulants and the risk of a first episode of deep venous thrombosisP G de Groot, B Lutters, R H W M Derksen, et al.

Journal of Thrombosis and Haemostasis : JTH|August 7, 2009

Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibalpha and alpha IIb beta 3C J C de Haas, C Weeterings, M M Vughs, et al.

Journal of Thrombosis and Haemostasis : JTH|October 18, 2013

Increased mortality in systemic inflammatory response syndrome patients with high levels of coagulation factor VIIaA Hyseni, H Kemperman, D W de Lange, et al.

Blood|August 1, 1995

Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factorH Lankhof, Y P Wu, T Vink, et al.

Stroke|February 1, 1993

Increased thromboxane biosynthesis in patients with acute cerebral ischemiaP J Koudstaal, G Ciabattoni, J van Gijn, et al.

Journal of Thrombosis and Haemostasis : JTH|November 25, 2003

Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinuxT Lisman, N R Bijsterveld, J Adelmeijer, et al.

Pageof 24